Matches in SemOpenAlex for { <https://semopenalex.org/work/W3195874124> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W3195874124 endingPage "S658" @default.
- W3195874124 startingPage "S658" @default.
- W3195874124 abstract "Introduction Clozapine is the most effective antipsychotic for treatment resistant schizophrenia but adverse reactions to clozapine include neutropenia. Patients with COVID-19 infection frequently experience lymphopenia, but not neutropenia.The impact of clozapine treatment in the presence of COVID-19 is unknown Objectives Show 2 cases of neutropenia in patients treated with long-term clozapine during COVID-19 infection. Methods Subjects: 48 admitted patients to a long-stay psychiatric unit. COVID-19 infection confirmed by positive nasopharyngeal swab for viral ribonucleic acid of SARS-CoV-2. Hematological controls between March and April 2020. Results 16 patients (33%) treated with clozapine.18 patients (37’5%) had COVID-19 infection, of which 5 (10’4%) were treated with clozapine; 2 presented neutropenia. 1- 56-year-old woman diagnosed with schizophrenia on clozapine since 2009. Begins to have a dry cough and fever with positive COVID-19 swab (day 0). Slight leukopenia without neutropenia was observed on day 1. On day 7, neutropenia was observed with an absolute neutrophil count (ANC) of 1100. We decided to suspend clozapine and to initiate daily hematological controls. The ANC on day 8 was 970. Over the next few days the ANC will progressively improve until neutropenia resolved (day 22). 2- 55-year-old woman who required a transfer to a general hospital because of respiratory complications from COVID-19. She presented significant leukopenia (1’01x 10^3/uL) and neutropenia (ANC 100). Clozapine was not withdrawn. She was treated with granulocyte colony-stimulating factor. Conclusions An urgent full blood count will be required to exclude neutropenia with appropriate action. Further research will be needed to clarify the possible relationship between COVID-19, clozapine and neutropenia. Disclosure No significant relationships." @default.
- W3195874124 created "2021-08-30" @default.
- W3195874124 creator A5024455032 @default.
- W3195874124 creator A5044093566 @default.
- W3195874124 creator A5044788979 @default.
- W3195874124 creator A5045150124 @default.
- W3195874124 creator A5048828544 @default.
- W3195874124 creator A5050279490 @default.
- W3195874124 creator A5064217667 @default.
- W3195874124 creator A5084137235 @default.
- W3195874124 creator A5090552016 @default.
- W3195874124 date "2021-04-01" @default.
- W3195874124 modified "2023-10-17" @default.
- W3195874124 title "Neutropenia in patients treated with clozapine during COVID-19 infection" @default.
- W3195874124 doi "https://doi.org/10.1192/j.eurpsy.2021.1748" @default.
- W3195874124 hasPublicationYear "2021" @default.
- W3195874124 type Work @default.
- W3195874124 sameAs 3195874124 @default.
- W3195874124 citedByCount "1" @default.
- W3195874124 countsByYear W31958741242022 @default.
- W3195874124 crossrefType "journal-article" @default.
- W3195874124 hasAuthorship W3195874124A5024455032 @default.
- W3195874124 hasAuthorship W3195874124A5044093566 @default.
- W3195874124 hasAuthorship W3195874124A5044788979 @default.
- W3195874124 hasAuthorship W3195874124A5045150124 @default.
- W3195874124 hasAuthorship W3195874124A5048828544 @default.
- W3195874124 hasAuthorship W3195874124A5050279490 @default.
- W3195874124 hasAuthorship W3195874124A5064217667 @default.
- W3195874124 hasAuthorship W3195874124A5084137235 @default.
- W3195874124 hasAuthorship W3195874124A5090552016 @default.
- W3195874124 hasBestOaLocation W31958741241 @default.
- W3195874124 hasConcept C118552586 @default.
- W3195874124 hasConcept C126322002 @default.
- W3195874124 hasConcept C187212893 @default.
- W3195874124 hasConcept C2776412080 @default.
- W3195874124 hasConcept C2776694085 @default.
- W3195874124 hasConcept C2777063308 @default.
- W3195874124 hasConcept C2780864610 @default.
- W3195874124 hasConcept C2780873365 @default.
- W3195874124 hasConcept C71924100 @default.
- W3195874124 hasConcept C74133956 @default.
- W3195874124 hasConcept C90924648 @default.
- W3195874124 hasConceptScore W3195874124C118552586 @default.
- W3195874124 hasConceptScore W3195874124C126322002 @default.
- W3195874124 hasConceptScore W3195874124C187212893 @default.
- W3195874124 hasConceptScore W3195874124C2776412080 @default.
- W3195874124 hasConceptScore W3195874124C2776694085 @default.
- W3195874124 hasConceptScore W3195874124C2777063308 @default.
- W3195874124 hasConceptScore W3195874124C2780864610 @default.
- W3195874124 hasConceptScore W3195874124C2780873365 @default.
- W3195874124 hasConceptScore W3195874124C71924100 @default.
- W3195874124 hasConceptScore W3195874124C74133956 @default.
- W3195874124 hasConceptScore W3195874124C90924648 @default.
- W3195874124 hasIssue "S1" @default.
- W3195874124 hasLocation W31958741241 @default.
- W3195874124 hasLocation W31958741242 @default.
- W3195874124 hasOpenAccess W3195874124 @default.
- W3195874124 hasPrimaryLocation W31958741241 @default.
- W3195874124 hasRelatedWork W1988899383 @default.
- W3195874124 hasRelatedWork W2055974778 @default.
- W3195874124 hasRelatedWork W2085933057 @default.
- W3195874124 hasRelatedWork W2116363772 @default.
- W3195874124 hasRelatedWork W2607295757 @default.
- W3195874124 hasRelatedWork W2765818638 @default.
- W3195874124 hasRelatedWork W3191315122 @default.
- W3195874124 hasRelatedWork W3195874124 @default.
- W3195874124 hasRelatedWork W4220915524 @default.
- W3195874124 hasRelatedWork W2416135570 @default.
- W3195874124 hasVolume "64" @default.
- W3195874124 isParatext "false" @default.
- W3195874124 isRetracted "false" @default.
- W3195874124 magId "3195874124" @default.
- W3195874124 workType "article" @default.